Toll-like receptor 2 induced angiogenesis and invasion is mediated through the tie2 signalling pathway in rheumatoid arthritis

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Saber, Tajvur ^a   Veale, Douglas J ^a   Balogh, Emese ^a   McCormick, Jennifer ^a   NicAnUltaigh, Sinead ^a   Connolly, Mary ^a   Fearon, Ursula ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; TOLL LIKE RECEPTOR 2; ANGIOPOIETIN 2; ANTIBODY; LIPOPEPTIDE; PAM(3)CSK(4) PEPTIDE;

ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN VITRO STUDY; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; TISSUE CULTURE CELL; ANGIOGENESIS; CELL CULTURE; CELL MOTION; DRUG EFFECT; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM; TISSUE CULTURE TECHNIQUE;

ANGIOPOIETIN-2; ANTIBODIES; ARTHRITIS, RHEUMATOID; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LIPOPEPTIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TISSUE CULTURE TECHNIQUES; TOLL-LIKE RECEPTOR 2;

EID: 80051728761     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023540     Document Type: Article

References (53)

1. Koch AE, (2003) Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62: 60-67.
2. Ferrara N, Davis-Smyth T, (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
3. Bucala R, Ritchlin C, Winchester R, Cerami A, (1991) Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173: 569-574.
4. Chu CQ, Field M, Allard S, Abney E, Feldmann M, et al. (1992) Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 10: 653-661.
5. Tak PP, Bresnihan B, (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43: 2619-2633.
6. Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, et al. (2003) Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162: 1221-1227.
7. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, et al. (2004) Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 2004 50: 1457-1467.
8. Schrijver IA, Melief MJ, Tak PP, Hazenberg MP, Laman JD, (2000) Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum 43: 2160-2168.
9. Brentano F, Kyburz D, Schorr O, Gay R, Gay S, (2005) The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell Immunol 233: 90-96.
10. Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, et al. (2007) The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007 170: 518-525.
11. Reece RJ, Canete JD, Parsons WJ, Emery P, Veale DJ, (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 42: 1481-1484.
12. Fearon U, Griosios K, Fraser A, Reece R, Emery P, et al. (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 200330: 260-268.
13. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, et al. (1994) Vascular endothelial growth factor A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994 152: 4149-4156.
14. Darland DC, D'Amore PA, (2001) TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 4: 11-20.
15. Lobov IB, Brooks PC, Lang RA, (2002) Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99: 11205-11210.
16. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, et al. (1998) Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83: 233-240.
17. Zhang J, Cao R, Zhang Y, Jia T, Cao Y, et al. (2009) Differential roles of PDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J pp. 23153-163.
18. Schomber T, Kopfstein L, Djonov V, Albrecht I, Baeriswyl V, et al. (2007) Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. Cancer Res 67: 10840-10848.
19. Radstake TR, Roelofs MF, Jenniskens YM, Oppers-Walgreen B, van Riel PL, et al. (2004) Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma. Arthritis Rheum 50: 3856-3865.
20. Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, et al. (2007) Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108: 121-128.
21. Varoga D, Paulsen F, Mentlein R, Fay J, Kurz B, et al. (2006) TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. J Pathol 210: 315-324.
22. Hayashi K, Hooper LC, Detrick B, Hooks JJ, (2009) HSV immune complex (HSV-IgG: IC) and HSV-DNA elicit the production of angiogenic factor VEGF and MMP-9. Arch Virol 154: 219-226.
23. Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, et al. (2006) Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum 54: 3152-3162.
24. Nic An Ultaigh S, Saber TP, McCormick J, Connolly M, Dellacasagrande J, et al. (2011) Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther Feb 23;13 (1): R33 [Epub ahead of Print].
25. Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, et al. (2010) Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 184: 6427-37.
26. Huang Q, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AR, et al. (2009) Heat Shockprotein 96 is elevated in rheumatoid arthritis and activates macrophages primarilty via TLR2 signalling. J Immunol 182: 4965-73.
27. Przybysz, Borysewicz K, Szechinski J, Katnik-Prastowska I, (2007) Synovial fibronection fragmentation and domain expressions in relation to rheumatoid arthritis progression. Rheumatology 46: 1071-1075.
28. Yu D, Rumore PM, Liu Q, Steinman CR, (1997) Soluble oligonucleaosomal complexes in synovial fluid from inflamed joints. Arthritis Rheum 40: 648-654.
29. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-81.
30. Szekanecz Z, Koch AE, (2004) Therapeutic inhibition of leukocyte recruitment in inflammatory diseases. Curr Opin Pharmacol 4: 423-428.
31. Monaco C, Gregan SM, Navin TJ, Foxwell BM, Davies AH, et al. (2009) Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 120: 2462-2469.
32. Grote K, Schuett H, Salguero G, Grothusen C, Jagielska J, et al. (2010) Toll-like receptor 2/6 stimulation promotes angiogenesis via GM-CSF as a potential strategy for immune defense and tissue regeneration. Blood 115: 2543-52.
33. Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE, (2002) Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4: 201-208.
34. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, et al. (2006) Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
35. Li Y, Xiang M, Yuan Y, Xiao G, Zhang J, et al. (2009) Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2. Am J Physiol Regul Integr Comp Physiol 2009 pp. 2971670-1680.
36. Sawa Y, Tsuruga E, Iwasawa K, Ishikawa H, Yoshida S, (2008) Leukocyte adhesion molecule and chemokine production through lipoteichoic acid recognition by toll-like receptor 2 in cultured human lymphatic endothelium. Cell Tissue Res 333: 237-252.
37. Nijhuis MM, Pasterkamp G, Sluis NI, de Kleijn DP, Laman JD, et al. (2007) Peptidoglycan increases firm adhesion of monocytes under flow conditions and primes monocyte chemotaxis. J Vasc Res 44: 214-222.
38. Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, et al. (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48: 642-650.
39. Nguyen M, Arkell J, Jackson CJ, (2001) Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33: 960-970.
40. Faveeuw C, Preece G, Ager A, (2001) Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98: 688-695.
41. Hitchon CA, Danning CL, Illei GG, El-Gabalawy HS, Boumpas DT, (2002) Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis. J Rheumatol 29: 107-117.
42. Chang YH, Lin IL, Tsay GJ, Yang SC, Yang TP, et al. (2008) Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Biochem 41: 955-959.
43. Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, et al. (2007) In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum 56: 2535-2548.
44. Donnini S, Morbidelli L, Taraboletti G, Ziche M, (2004) ERK1-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium. Life Sci 74: 2975-2985.
45. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, et al. (1999) Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF. Science 284: 1994-1998.
46. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, et al. (1997) Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis. Science 277: 55-60.
47. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, et al. (1996) Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis. Cell 87: 1171-1180.
48. Kasama T, Isozaki T, Odai T, Matsunawa M, Wakabayashi K, et al. (2007) Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma. Translational Research 149: 265-273.
49. Takahara K, Iioka T, Furukawa K, Uchida T, Nakashima M, et al. (2004) Autocrine/paracrine role of the angiopoietin-1 and-2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis. Human Pathology 35: 150-158.
50. Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, et al. (2003) Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor-alpha. Ann Rheum Dis 62: 100-107.
51. Scott B, Zaratin P, Colombo A, Hansbury M, Winkler J, et al. (2002) Constitutive Expression of Angiopoietin-1 and-2 and Modulation of Their Expression by Inflammatory Cytokines in Rheumatoid Arthritis Synovial Fibroblasts. Journal of Rheumatology 29: 230-239.
52. Chen Y, Donnelly E, Kobayashi H, DeBusk LM, Lin PC, (2005) Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. ArthritisRheum 52: 1585-1594.53.
53. DeBusk LM, Chen Y, Nishishita T, Chen J, Thomas JW, et al. (2003) Tie2 receptor tyrosine kinase, a major mediator of tumor necrosis factor alpha-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 48: 2461-2471.